Venture Capital Venture Capital

Ontario passes new law – Global Arbitration Review

A new international commercial arbitration act for Ontario came into force on March 22, 2017, which replaces the International Commercial Arbitration...

Mylan remporte la bataille au sujet du brevet relatif à une combinaison de médicaments contre l’arthrite– Legal Feeds

La Cour fédérale du Canada a récemment rendu la première décision mondiale portant sur la validité d’un brevet relatif à la formulation de...

OPTrust punches above its weight with private equity strategy — The PE Hub Network

Osler partner John Groenewegen says OPTrust’s strategy to expand its private equity program has “put them in a position they would not otherwise...

Passing the FinTech test — Canadian Lawyer

FinTech firms are subject to the same financial regulatory compliance issues as their traditional financial services counterparts, yet the existing...

Climate legislation is a work in progress full of risks energy companies can’t ignore — JWN Energy

Energy companies in Canada must be prepared for how the federal Liberal government’s Pan-Canadian Framework on Clean Growth and Climate Change (the...

Focus: Change within firms driven by different factors – Law Times

Law firms are under increasing pressure to change the way they practise, often turning to technological innovations to improve efficiencies and...

Mylan wins in patent battle over combo arthritis drug – Legal Feeds

The Federal Court of Canada recently issued the world’s first ruling on the validity of a VIMOVO® formulation patent in AstraZeneca Canada Inc v...

A look at Québec’s pension solvency changes one year on – Benefits Canada

The landmark shift last year by Québec to going-concern funding obligations for defined benefit pension plans is benefiting employers, according to...

Experts baffled over Canada credit card probe — PaymentsCompliance

Osler partner Kashif Zaman says there is “no evidence of widespread abuse by banks” in terms of non-consensual credit card issuance in Canada, in...

Canadian court issues world’s first VIMOVO patent judgment

In a recent decision by the Federal Court of Canada, a generic version of a popular anti-inflammatory combination drug will be made available for the...